Popular weight loss drug does not appear to worsen diabetic eye disease in most patients, new study suggests
In the following sections, we will explore how to know if you are ready to make a change and what restarting the medication might look like
In this study, 306 patients with type 2 diabetes inadequately controlled with metformin (1500 mg) alone were randomly assigned to 8 weeks of double-blind subcutaneous treatment with placebo or taspoglutide, either 5, 10, or 20 mg once weekly or 10 or 20 mg once every 2 weeks, and followed for 4 additional weeks
In contrast, the decline in new patient volume for GERD products slowed during the same period, consistent with evidence that GLP-1s can worsen reflux symptoms
The company quickly had to backpedal amid legal action from Novo Nordisk